NCT04737213View on ClinicalTrials.gov

SGM-101 in Colorectal Lung Metastases

PHASE2UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

November 1, 2021

Study Completion Date

December 1, 2021

Conditions
Colorectal CancerMetastatic Colon Cancer
Interventions
DRUG

SGM-101

Fluorescence guided surgery

Trial Locations (2)

2333 ZA

RECRUITING

Leiden University Medical Center, Leiden

Unknown

NOT_YET_RECRUITING

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

Surgimab

INDUSTRY

lead

Leiden University Medical Center

OTHER

NCT04737213 - SGM-101 in Colorectal Lung Metastases | Biotech Hunter | Biotech Hunter